Literature DB >> 15584213

Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1 (NF1): report of a case with long-term survival.

H Kroh1, E Matyja, A Marchel, P Bojarski.   

Abstract

Giant cell glioblastoma (GCG-BM) with predominance of bizarre, multinucleated giant cells is a rare subtype of glioblastoma, however, its clinical behavior and histological features are still not fully understood. We report an unusual case of a heavily lipidized form of giant cell glioma corresponding mostly to GCGBM in a young patient with neurofibromatosis 1 (NF1). Histologically, the tumor revealed numerous characteristic histopathological features of giant cell glioblastoma including cellular pleomorphism with numerous giant tumor cells, pseudopalisades around necrotic foci and mitotic activity, accompanied by additional unique morphological elements such as massive lipidization of the neoplastic cells, abundant microcalcifications and angiomatous pattern of vascularization. Such aberrant morphology might be associated with the unusually long survival period of 12 years without clinical evidence of tumor recurrence. The coexistence of intracerebral heavily lipidized, calcified giant cell glioblastoma with NF1 has not been previously reported in literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15584213

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  10 in total

1.  Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.

Authors:  Brett J Theeler; Benjamin Ellezam; Shlomit Yust-Katz; John M Slopis; Monica E Loghin; John F de Groot
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

2.  Pediatric giant cell glioblastoma: New insights into a rare tumor entity.

Authors:  Michael Karremann; Sandra Butenhoff; Ulrike Rausche; Torsten Pietsch; Johannes E A Wolff; Christof M Kramm
Journal:  Neuro Oncol       Date:  2008-12-02       Impact factor: 12.300

3.  Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.

Authors:  Kevin R Kozak; John S Moody
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

4.  Giant cell glioblastoma in a child: A rare case report.

Authors:  S K Jain; I Vijay Sundar; V D Sinha; Vinod Sharma; Vishal Bhasme; Ravishankar S Goel
Journal:  Asian J Neurosurg       Date:  2012-07

5.  Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.

Authors:  Amro K Bin Abdulrahman; Khalid A Bin Abdulrahman; Yousef R Bukhari; Abdulaziz M Faqihi; Juan Gabriel Ruiz
Journal:  Brain Behav       Date:  2019-08-29       Impact factor: 2.708

6.  Pediatric Giant Cell Glioblastoma Presenting with Intracranial Dissemination at Diagnosis: A Case Report.

Authors:  Takamasa Kinoshita; Hirohito Yano; Noriyuki Nakayama; Natsuko Suzui; Tomohiro Iida; Saori Endo; Shiho Yasue; Michio Ozeki; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Toru Iwama
Journal:  NMC Case Rep J       Date:  2021-06-05

7.  A petroclival glioma mimicking trigeminal schwannoma: A case report.

Authors:  Hui-Min Xie; Seidu A Richard; Zhigang Lan
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

8.  Giant cell glioblastoma in the pediatric age group: Report of two cases.

Authors:  Sachin Anil Borkar; G Lakshmiprasad; Kiran Chikkanahalli Subbarao; Mehar Chand Sharma; Ashok K Mahapatra
Journal:  J Pediatr Neurosci       Date:  2013-01

9.  Giant Cell Glioblastoma in a Child with Clinical and Family History of Neurofibromatosis.

Authors:  Ishita Pant; Wajid Nazir; Vinita Ujjawal; Sujata Chaturvedi
Journal:  Asian J Neurosurg       Date:  2017 Oct-Dec

10.  Altered Elemental Distribution in Male Rat Brain Tissue as a Predictor of Glioblastoma Multiforme Growth-Studies Using SR-XRF Microscopy.

Authors:  Karolina Planeta; Zuzanna Setkowicz; Mateusz Czyzycki; Natalia Janik-Olchawa; Damian Ryszawy; Krzysztof Janeczko; Rolf Simon; Tilo Baumbach; Joanna Chwiej
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.